The FTLD-TDP43 group had significantly higher scores than the early-onset Alzheimer’s disease and DLB groups based on the OF, AT and MTA scales (P< 0.05), and the late-onset Alzheimer’s disease group based on the AC and AT scales (P< 0.05). The gene discussed is TARDBP; the disease is Alzheimer disease.